Artelo Biosciences, Inc.
ARTL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001621221
No open-market purchases or sales by Artelo Biosciences, Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $132.0K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Artelo Biosciences, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 9 | 10 | +1 |
| Shares | 33.0K | 98.5K | +65.5K (+198.1%) |
| Value | $151.7K | $120.6K | −$31.1K (−20.5%) |
New holders (6)
Institutions that held Artelo Biosciences, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 20,669 | $25.2K | 0.00% |
| Virtu Financial LLC | 16,865 | $21.0K | 0.00% |
| Geode Capital Management, LLC | 11,398 | $13.9K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,903 | $2.32K | 0.00% |
| Advisor Group Holdings, Inc. | 1 | $1 | 0.00% |
| CWM, LLC | 1 | $0 | 0.00% |
Sold out (5)
Institutions that held Artelo Biosciences, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| DRW Securities, LLC | 17,185 | $78.9K |
| Morgan Stanley | 1,100 | $5.05K |
| Citigroup Inc | 477 | $2.19K |
| FMR LLC | 30 | $138 |
| Royal Bank of Canada | 1 | $0 |